2Epstein S. Update of current therapeutic options for the treatmentof post- menopausal osteoporosis[J]. Clin Ther,2006,28(2) : 151 - 173.
3Fleisch H,Russell RGG,Francis MD.Biphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.Science,1969,165:1262-1264.
4Iwamoto J,Sato Y,Takeda T,Matsumoto H.Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis:a review of the literature.Clin Interv Aging,2008,3:483-489.
6Ho YV,Frauman AG,Thomson W,et al.Effects of alendronate on bone density in men with primary and secondary osteo-porosis.Osteoporos Int,2000,11:98-101.
7Tucci JR,Tonino RP,Emkety RD,et al.Effect of three years of oral alendronate treatment in postmenopausal women with osteo-porosis.Am J Med,1996,101:488-501.
